Cengild Medical Berhad (KLSE: CENGILD)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.275
+0.005 (1.85%)
At close: Dec 20, 2024

Cengild Medical Berhad Company Description

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia.

The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, endocrinology, general surgery, internal medicine, orthopedic, plastic and reconstructive surgery, radiology, rheumatology, and thoracic surgery; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery; and chemotherapy.

It also provides medical management services; nursing services and clinical support services; clinical laboratory and pharmacy; radiology and imaging services; dietetics and nutrition, physiotherapy, and medical record services; accident and emergency care, and health screenings; and consultant services.

Cengild Medical Berhad was founded in 2017 and is based in Kuala Lumpur, Malaysia.

Cengild Medical Berhad
Country Malaysia
Founded 2017
Industry Health Services
Employees 159
CEO Wai Lee

Contact Details

Address:
Nexus @ Bangsar South
Kuala Lumpur, 59200
Malaysia
Phone 60 3 2242 7000
Website cengild.com

Stock Details

Ticker Symbol CENGILD
Exchange Bursa Malaysia
Fiscal Year July - June
Reporting Currency MYR
SIC Code 8000

Key Executives

Name Position
Wai Lee Chief Executive Officer
Yoon Lian Chief Financial Officer